evaluated
thalidomide-induced neuropathy
electrodiagnostic studies
men
metastatic
open-label trial
oral
thalidomide
neurologic examinations
nerve conduction studies
NCS
intervals
treatment
NCS
recording
sensory nerve action potentials
SNAPs
median
radial
ulnar
sural nerves
SNAP
amplitudes
nerve
expressed
baseline
SNAP index
decline
SNAP index
clinically significant
Thalidomide
discontinued
patients
therapeutic response
patients
thalidomide
months
months
months
patients
neuropathy
Clinical symptoms
decline
SNAP index
concurrently
Older age
cumulative dose
factors
Neuropathy
complication
thalidomide
older patients
SNAP index
peripheral neuropathy
early
detection
